This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Iowa Research Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Mirac Nedim Ince: Innovator in Graft Versus Host Disease Treatment
Introduction
Mirac Nedim Ince is a notable inventor based in Iowa City, IA. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of graft versus host disease (GVHD). His innovative work focuses on the use of helminthic parasite preparations, which have the potential to improve outcomes for transplant patients.
Latest Patents
Mirac Nedim Ince holds a patent for "Parasitic biological agents for treatment and prevention of graft versus host disease." This invention relates to helminthic parasite preparations and their application in treating or preventing GVHD in subjects who have undergone a transplant. Additionally, it addresses the use of these preparations for preventing GVHD in subjects prior to a transplant. He has 1 patent to his name.
Career Highlights
Ince is affiliated with the University of Iowa Research Foundation, where he conducts his research and develops his innovative ideas. His work has the potential to transform the way GVHD is managed, offering new hope to patients undergoing transplants.
Collaborations
Mirac Nedim Ince collaborates with esteemed colleagues such as David E Elliott and George J Weiner. Their combined expertise enhances the research efforts and contributes to the advancement of medical treatments.
Conclusion
Mirac Nedim Ince is a pioneering inventor whose work in the treatment of graft versus host disease showcases the importance of innovation in medical science. His contributions are vital for improving patient care and outcomes in transplant medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
